Hamptons Homebuildi...
Health Care: Drugs
Elite Pharmaceuticals Inc. (ELTP: OTC)
$0.07 0.00 | 0.00%
05/24/13 - 03:59 PM ET
1.67M / 1.03M
Vol / Avg. Vol:0.07 / 0.07
Open / Prev. Close:0.06 - 0.07
Today's Range:0.05 - 0.15
52 Wk Range:-12.77%
Performance YTD:TheStreet Rating:
Portfolios with ELTP
- Portfolio NameUser Type
- UserMark
Latest ELTP Headlines from TheStreet
- Elite Pharmaceuticals Announces Change In Executive Leadership 05.21.13 | 11:05 am
- Elite Pharmaceuticals Awarded Second U.S. Patent For Abuse Resistant Drug Formulation 04.23.13 | 08:04 am
- Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC 04.22.13 | 08:04 am
- Elite Pharmaceuticals, Inc. Announces First Shipment Of Generic Phentermine Capsules 04.11.13 | 08:04 am
- Elite Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of Fiscal 2013 02.14.13 | 04:02 pm
- Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Third Quarter Investor Conference Call On Tuesday, February 19, 2013 02.13.13 | 08:02 am
- Elite Pharmaceuticals Announces FDA Approval Of Supplemental Application For Naltrexone 02.06.13 | 08:02 am
- Elite Pharmaceuticals, Inc. Announces First Shipments From Expanded 15,000 Square Foot Facility 01.28.13 | 08:01 am
- Elite Pharmaceuticals, Inc. Announces Agreement For Supply Of Phentermine Active Ingredient 12.13.12 | 08:12 am
- Elite Pharmaceuticals Announces Amendment To Bridge Loan Facility 12.10.12 | 08:12 am
Press Releases for ELTP
Partner Headlines for ELTP
